External funding opportunities

On this page, EB-ResNet provides information on external funding possibilities. We do not intend to give a complete overview of funding possibilities but display interesting calls and information about other funding sources relevant for persons involved in EB research.

Upcoming and current external calls

INNOVATIVE MEDICINES INITIATIVE: IMI-2 - Call 20

"Research Projects on Personalised Medicine - Pre-/Clinical research, Big Data and ICT, Implementaion and User's Perspective"

Most interesting Topics

Submission deadlines

Call for proposals will be launched: 21 January 2020

Submission for pre-proposals: 21 April 2020

Contact

FFG - Austrian Research Promotion Agency

Dr. Astrid Hoebertz: astrid.hoebertz@ffg.at

!!! Please note: More interesting calls will be launched on 23 June 2020, such as

Clinical outcomes assessments for rare diseases
Real-world clinical implementation of liquid biopsy
Microbiome

IMI-2-Call 20 Details and submission

AFM TELETHON 2020 call

AFM TELETHON supports research into gene and/or cell therapy of rare disorders, through Postdoctoral Fellowships, PhD Fellowships and Research grants.

This International Call for Proposals is open to both French and foreign teams:

Call: "Development of therapeutic approaches for rare genetic diseases."

1 Gene and/or cell therapy for rare genetic disorders

Breakthrough innovation
Gene transfer and gene correction
Genome editing
Genetically modified cells
Development of delivery strategies
Control of the immune response (auto-immunity, anti-vector and anti-transgene responses, etc.)

2 Strategies for modifying gene expression both at the gene and RNA level

Projects based on gene transfer, chemical molecules or biotherapies

For new applications for Research Grants, Trampoline Grants and Postdoctoral Fellowships:

Deadline for submission of applications: 21 January 2020.
Results: mid-July 2020.

For new applications for PhD fellowships:

Deadline for submission of applications: 7 April 2020
Results: July 2020

AFM Call details and submission

European Joint Programme on Rare Diseases (EJP RD) – Joint Transnational Call 2020

Call: “Pre-clinical research to develop effective therapies for rare diseases"

Aim

To build a collaboration (4-6 eligible principal investigator partners) on a common interdisciplinary research project based on complementarities and sharing of expertise, with a clear benefit for patients.

Topic

Development of novel therapies in a preclinical setting (including small molecules, repurposing drugs, cell and gene advanced therapies)
Use of disease models suitable for medicinal product’s development
Development of predictive and pharmacodynamics (PD) biomarkers in a preclinical setting
Proof of principle studies fostering an early (pre-clinical) stage of drug development

Submission deadlines
Pre-proposal: 12 February 2020
Full proposal: 16 June 2020

Contact FWF

Stephanie Resch

Phone: +43 (1) 505 67 40 82 01

E-Mail: stephanie.resch@fwf.ac.at

EJP RD Call details and submission

Worldwide Cancer Research (WWCR)

Aim

This yearly funding opportunity supports novel and innovative basic, fundamental and translational research into prevention, diagnosis or treatment of cancer.

Restrictions: WWCR do NOT support clinical research, including clinical trials, patient care, nursing or healthcare delivery research, policy, public health or psychosocial research.

Submission deadline 7 April 2020

Budget

The maximum Budget is £250,000, however, most of the three-year grants awarded have a budget below £200,000.

Grant duration

12 to 36 months

More information

Eligibility criteria: https://www.worldwidecancerresearch.org/for-researchers/our-funding-criteria/

Application process:https://www.worldwidecancerresearch.org/for-researchers/our-application-process/

Contact

grants@worldwidecancerresearch.org

WWCR Portal Application